Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 1—January 2023
Research

Human Immunity and Susceptibility to Influenza A(H3) Viruses of Avian, Equine, and Swine Origin

Elien Vandoorn, Wojciech Stadejek, Isabel Leroux-Roels, Geert Leroux-Roels, Anna Parys, and Kristien Van ReethComments to Author 
Author affiliations: Ghent University, Merelbeke, Belgium (E. Vandoorn, W. Stadejek, A. Parys, K. Van Reeth); Ghent University and Ghent University Hospital, Ghent, Belgium (I. Leroux-Roels, G. Leroux-Roels)

Main Article

Figure 5

TEER of human airway epithelia (MucilAir; Epithelix Sàrl, https://www.epithelix.com) at different days postinfection with influenza A(H3) viruses of different species at a multiplicity of infection of 0.01 50% tissue culture infective dose. TEER is shown for nasal tissue of donors ND1 (A), ND2 (B), and ND3 (C) and for bronchial tissue of donors BD1 (E), BD2 (F), and BD3 (G). Black dashed lines represent the TEER below which tissue integrity is irreversibly lost (37). Complete isolate names are provided in Table 2. TEER, transepithelial electrical resistance.

Figure 5. TEER of human airway epithelia (MucilAir; Epithelix Sàrl, https://www.epithelix.com) at different days postinfection with influenza A(H3) viruses of different species at a multiplicity of infection of 0.01 50% tissue culture infective dose. TEER is shown for nasal tissue of donors ND1 (A), ND2 (B), and ND3 (C) and for bronchial tissue of donors BD1 (E), BD2 (F), and BD3 (G). Black dashed lines represent the TEER below which tissue integrity is irreversibly lost (37). Complete isolate names are provided in [[ANCHOR###T2###Table 2###Anchor]]. TEER, transepithelial electrical resistance.

Main Article

References
  1. Fang  R, Min Jou  W, Huylebroeck  D, Devos  R, Fiers  W. Complete structure of A/duck/Ukraine/63 influenza hemagglutinin gene: animal virus as progenitor of human H3 Hong Kong 1968 influenza hemagglutinin. Cell. 1981;25:31523.
  2. Bailey  E, Long  LP, Zhao  N, Hall  JS, Baroch  JA, Nolting  J, et al. Antigenic characterization of H3 subtypes of avian influenza A viruses from North America. Avian Dis. 2016;60(Suppl):34653.
  3. Pu  J, Liu  QF, Xia  YJ, Fan  YL, Brown  EG, Tian  FL, et al. Genetic analysis of H3 subtype influenza viruses isolated from domestic ducks in northern China during 2004–2005. Virus Genes. 2009;38:13642.
  4. Woodward  A, Rash  AS, Medcalf  E, Bryant  NA, Elton  DM. Using epidemics to map H3 equine influenza virus determinants of antigenicity. Virology. 2015;481:18798.
  5. World Organisation for Animal Health. OIE expert surveillance panel on equine influenza vaccine composition. 2020 Apr 16 [cited 2021 Aug 27]. https://oiebulletin.fr/?officiel=08-4-2-2020-1-panel
  6. Anderson  TK, Chang  J, Arendsee  ZW, Venkatesh  D, Souza  CK, Kimble  JB, et al. Swine influenza A viruses and the tangled relationship with humans. Cold Spring Harb Perspect Med. 2021;11:a038737.
  7. Qiu  Y, Muller  CP, Van Reeth  K. Lower seroreactivity to European than to North American H3N2 swine influenza viruses in humans, Luxembourg, 2010. Euro Surveill. 2015;20:2533.
  8. Lorbach  JN, Fitzgerald  T, Nolan  C, Nolting  JM, Treanor  JJ, Topham  DJ, et al. Gaps in serologic immunity against contemporary swine-origin influenza A viruses among healthy individuals in the United States. Viruses. 2021;13:127.
  9. Krumbholz  A, Lange  J, Dürrwald  R, Walther  M, Müller  TH, Kühnel  D, et al. Prevalence of antibodies to European porcine influenza viruses in humans living in high pig density areas of Germany. Med Microbiol Immunol (Berl). 2014;203:1324.
  10. Hoschler  K, Thompson  C, Casas  I, Ellis  J, Galiano  M, Andrews  N, et al. Population susceptibility to North American and Eurasian swine influenza viruses in England, at three time points between 2004 and 2011. Euro Surveill. 2013;18:20578.
  11. US Centers for Disease Control and Prevention. Novel influenza A virus infections [cited 2021 Nov 21]. https://gis.cdc.gov/grasp/fluview/Novel_Influenza.html
  12. Freidl  GS, Meijer  A, de Bruin  E, de Nardi  M, Munoz  O, Capua  I, et al. FLURISK Consortium. Influenza at the animal-human interface: a review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A(H5N1). Euro Surveill. 2014;19:20793.
  13. Piralla  A, Moreno  A, Orlandi  ME, Percivalle  E, Chiapponi  C, Vezzoli  F, et al.; Influenza Surveillance Study Group. Swine influenza A(H3N2) virus infection in immunocompromised man, Italy, 2014. Emerg Infect Dis. 2015;21:118991.
  14. Xie  T, Anderson  BD, Daramragchaa  U, Chuluunbaatar  M, Gray  GC. A review of evidence that equine influenza viruses are zoonotic. Pathogens. 2016;5:310.
  15. Baz  M, Paskel  M, Matsuoka  Y, Zengel  J, Cheng  X, Jin  H, et al. Replication and immunogenicity of swine, equine, and avian H3 subtype influenza viruses in mice and ferrets. J Virol. 2013;87:690110.
  16. Steensels  M, Gelaude  P, Van Borm  S, Van Den Berg  T, Cargnel  M, Roupie  V, et al. Atypical pathogenicity of avian influenza (H3N1) virus involved in outbreak, Belgium, 2019. Emerg Infect Dis. 2020;26:1899903.
  17. Tan  X, Yan  X, Liu  Y, Wu  Y, Liu  JY, Mu  M, et al. A case of human infection by H3N8 influenza virus. Emerg Microbes Infect. 2022;11:22147.
  18. World Health Organization. Tool for Influenza Pandemic Risk Assessment (TIPRA) version 1. 2016 May [cited 2021 Sept 28]. https://apps.who.int/iris/handle/10665/250130
  19. Fragaszy  E, Ishola  DA, Brown  IH, Enstone  J, Nguyen-Van-Tam  JS, Simons  R, et al.; Flu Watch Group. Combating Swine Influenza (COSI) Consortium. Increased risk of A(H1N1)pdm09 influenza infection in UK pig industry workers compared to a general population cohort. Influenza Other Respir Viruses. 2016;10:291300.
  20. Sikkema  RS, Freidl  GS, de Bruin  E, Koopmans  M. Weighing serological evidence of human exposure to animal influenza viruses - a literature review. Euro Surveill. 2016;21:30388.
  21. Zhou  N, He  S, Zhang  T, Zou  W, Shu  L, Sharp  GB, et al. Influenza infection in humans and pigs in southeastern China. Arch Virol. 1996;141:64961.
  22. Burnell  FJ, Holmes  MA, Roiko  AH, Lowe  JB, Heil  GL, White  SK, et al. Little evidence of human infection with equine influenza during the 2007 epizootic, Queensland, Australia. J Clin Virol. 2014;59:1003.
  23. Khurelbaatar  N, Krueger  WS, Heil  GL, Darmaa  B, Ulziimaa  D, Tserennorov  D, et al. Little evidence of avian or equine influenza virus infection among a cohort of Mongolian adults with animal exposures, 2010-2011. PLoS One. 2014;9:e85616.
  24. Larson  KR, Heil  GL, Chambers  TM, Capuano  A, White  SK, Gray  GC. Serological evidence of equine influenza infections among persons with horse exposure, Iowa. J Clin Virol. 2015;67:7883.
  25. Ilyushina  NA, Ikizler  MR, Kawaoka  Y, Rudenko  LG, Treanor  JJ, Subbarao  K, et al. Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium. J Virol. 2012;86:1172534.
  26. Shin  DL, Yang  W, Peng  JY, Sawatsky  B, von Messling  V, Herrler  G, et al. Avian influenza A virus infects swine airway epithelial cells without prior adaptation. Viruses. 2020;12:589.
  27. Sun  X, Pulit-Penaloza  JA, Belser  JA, Pappas  C, Pearce  MB, Brock  N, et al. Pathogenesis and transmission of genetically diverse swine-origin H3N2 variant influenza A viruses from multiple lineages isolated in the United States, 2011–2016. J Virol. 2018;92:e0066518.
  28. Driskell  EA, Jones  CA, Stallknecht  DE, Howerth  EW, Tompkins  SM. Avian influenza virus isolates from wild birds replicate and cause disease in a mouse model of infection. Virology. 2010;399:2809.
  29. Solórzano  A, Foni  E, Córdoba  L, Baratelli  M, Razzuoli  E, Bilato  D, et al. Cross-species infectivity of H3N8 influenza virus in an experimental infection in swine. J Virol. 2015;89:11190202.
  30. Walia  RR, Anderson  TK, Vincent  AL. Regional patterns of genetic diversity in swine influenza A viruses in the United States from 2010 to 2016. Influenza Other Respir Viruses. 2019;13:26273.
  31. Henritzi  D, Petric  PP, Lewis  NS, Graaf  A, Pessia  A, Starick  E, et al. Surveillance of European domestic pig populations identifies an emerging reservoir of potentially zoonotic swine influenza A viruses. Cell Host Microbe. 2020;28:614627.e6.
  32. Choi  JG, Kang  HM, Kim  MC, Paek  MR, Kim  HR, Kim  BS, et al. Genetic relationship of H3 subtype avian influenza viruses isolated from domestic ducks and wild birds in Korea and their pathogenic potential in chickens and ducks. Vet Microbiol. 2012;155:14757.
  33. Kumar  S, Stecher  G, Tamura  K. MEGA7: Molecular Evolutionary Genetics Analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33:18704.
  34. Rajão  DS, Gauger  PC, Anderson  TK, Lewis  NS, Abente  EJ, Killian  ML, et al. Novel reassortant human-like H3N2 and H3N1 influenza A viruses detected in pigs are virulent and antigenically distinct from swine viruses endemic to the United States. J Virol. 2015;89:1121322.
  35. Van Reeth  K, Gregory  V, Hay  A, Pensaert  M. Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes. Vaccine. 2003;21:137581.
  36. Van Poucke  SG, Nicholls  JM, Nauwynck  HJ, Van Reeth  K. Replication of avian, human and swine influenza viruses in porcine respiratory explants and association with sialic acid distribution. Virol J. 2010;7:38.
  37. Boda  B, Benaoudia  S, Huang  S, Bonfante  R, Wiszniewski  L, Tseligka  ED, et al. Antiviral drug screening by assessing epithelial functions and innate immune responses in human 3D airway epithelium model. Antiviral Res. 2018;156:729.
  38. Liu  F, Levine  MZ. Heterologous antibody responses conferred by A(H3N2) variant and seasonal influenza vaccination against newly emerged 2016–2018 A(H3N2) variant viruses in healthy persons. Clin Infect Dis. 2020;71:306170.
  39. Ciminski  K, Chase  GP, Beer  M, Schwemmle  M. Influenza A viruses: understanding human host determinants. Trends Mol Med. 2021;27:10412.
  40. Stewart  CE, Torr  EE, Mohd Jamili  NH, Bosquillon  C, Sayers  I. Evaluation of differentiated human bronchial epithelial cell culture systems for asthma research. J Allergy (Cairo). 2012;2012:943982.
  41. Fonville  JM, Wilks  SH, James  SL, Fox  A, Ventresca  M, Aban  M, et al. Antibody landscapes after influenza virus infection or vaccination. Science. 2014;346:9961000.
  42. Guan  L, Shi  J, Kong  X, Ma  S, Zhang  Y, Yin  X, et al. H3N2 avian influenza viruses detected in live poultry markets in China bind to human-type receptors and transmit in guinea pigs and ferrets. Emerg Microbes Infect. 2019;8:128090.
  43. Smith  DJ, Lapedes  AS, de Jong  JC, Bestebroer  TM, Rimmelzwaan  GF, Osterhaus  AD, et al. Mapping the antigenic and genetic evolution of influenza virus. Science. 2004;305:3716.
  44. de Jong  JC, Smith  DJ, Lapedes  AS, Donatelli  I, Campitelli  L, Barigazzi  G, et al. Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe. J Virol. 2007;81:431522.
  45. Tharakaraman  K, Raman  R, Stebbins  NW, Viswanathan  K, Sasisekharan  V, Sasisekharan  R. Antigenically intact hemagglutinin in circulating avian and swine influenza viruses and potential for H3N2 pandemic. Sci Rep. 2013;3:1822.
  46. Broberg  E, Nicoll  A, Amato-Gauci  A. Seroprevalence to influenza A(H1N1) 2009 virus—where are we? Clin Vaccine Immunol. 2011;18:120512.
  47. Long  JS, Mistry  B, Haslam  SM, Barclay  WS. Host and viral determinants of influenza A virus species specificity. Nat Rev Microbiol. 2019;17:6781.
  48. Borkenhagen  LK, Salman  MD, Ma  MJ, Gray  GC. Animal influenza virus infections in humans: a commentary. Int J Infect Dis. 2019;88:1139.
  49. Sorrell  EM, Schrauwen  EJA, Linster  M, De Graaf  M, Herfst  S, Fouchier  RAM. Predicting ‘airborne’ influenza viruses: (trans-) mission impossible? Curr Opin Virol. 2011;1:63542.

Main Article

Page created: November 30, 2022
Page updated: December 21, 2022
Page reviewed: December 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external